Switching to systemic therapy after locoregional treatment failure: Definition and best timing
Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato
Clin Mol Hepatol. 2020;26(2):155-162.   Published online 2020 Jan 15     DOI: https://doi.org/10.3350/cmh.2019.0021n
Citations to this article as recorded by Crossref logo
Diaphragmatic perforation after transcatheter arterial chemoembolization of hepatocellular carcinoma via inferior phrenic artery: a case report
Ji Soo Kim, Hyoung Nam Lee, Woong Hee Lee, Suk Hyun Bae
BMC Gastroenterology.2022;[Epub]     CrossRef
Successful Combined S Systemic-Regional Chemotherapy for Advanced Intrahepatic Cholangiocarcinoma: Report of Two Cases
P. G. Tarazov, T. I. Kagacheva, A. A. Polikarpov, A. V. Moiseenko
Journal of oncology: diagnostic radiology and radiotherapy.2022; 5(1): 83.     CrossRef
Nationwide database analysis of insomnia, depression, and sleeping pill prescriptions in hepatocellular carcinoma patients
Keishi Akada, Noriyuki Koyama, Yuji Miura, Ken Aoshima
Current Medical Research and Opinion.2022; : 1.     CrossRef
Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Pil Soo Sung
Clinical and Molecular Hepatology.2022; 28(3): 333.     CrossRef
Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta‐analysis
Han Ah Lee, Sunmin Park, Yeon Seok Seo, Won Sup Yoon, In‐Soo Shin, Chai Hong Rim
Journal of Hepato-Biliary-Pancreatic Sciences.2021; 28(12): 1031.     CrossRef
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
Cyrill Wehling, Michael T. Dill, Alexander Olkus, Christoph Springfeld, De-Hua Chang, Patrick Naumann, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Uta Merle, Jan Pfeiffenberger, Christian Rupp, Karl Heinz Weiss, Markus Mieth
Journal of Cancer Research and Clinical Oncology.2021; 147(8): 2471.     CrossRef
Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura
Clinical and Molecular Hepatology.2021; 27(4): 616.     CrossRef
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
International Journal of Molecular Sciences.2021; 22(18): 10027.     CrossRef
Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis
Yanmei Dai, Huijie Jiang, Hao Jiang, Sheng Zhao, Xu Zeng, Ran Sun, Ruoshui Zheng
Translational Oncology.2021; 14(12): 101238.     CrossRef
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Cancers.2021; 14(1): 67.     CrossRef
Liver Injury and Use of Contrast-Enhanced Ultrasound for Evaluating Intrahepatic Recurrence in a Case of TACE-Refractory Hepatocellular Carcinoma Receiving Atezolizumab-Bevacizumab Combination Therapy: A Case Report
Satoshi Komiyama, Kazushi Numata, Katsuaki Ogushi, Makoto Chuma, Reiko Tanaka, Sawako Chiba, Masako Otani, Yoshiaki Inayama, Masayuki Nakano, Shin Maeda
Diagnostics.2021; 11(8): 1394.     CrossRef
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival
Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka, Takashi Niizeki, Tomotake Shirono, Akira Kajiwara, Yu Noda, Naoki Kamachi, Shusuke Okamura, Masahito Nakano, Ryoko Kuromatsu, Takumi Kawaguchi, Hironori Koga, Takuji Torimura
Oncology.2021; 99(12): 756.     CrossRef
Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
Pil Soo Sung, Jeong Won Jang, Jaejun Lee, Soon Kyu Lee, Hae Lim Lee, Hyun Yang, Hee Chul Nam, Sung Won Lee, Si Hyun Bae, Jong Young Choi, Nam Ik Han, Seung Kew Yoon
Frontiers in Oncology.2020;[Epub]     CrossRef
Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
Zheng Guo, Jing Wang, Li Li, Rong Liu, Jin Fang, Bin Tie
World Journal of Clinical Cases.2020; 8(16): 3493.     CrossRef
Initial treatment response to transarterial chemoembolization as a predictive factor for Child–Pugh class deterioration prior to refractoriness in hepatocellular carcinoma
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasuharu Imai, Masahide Oshita, Kazuyoshi Ohkawa, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Hepatology Research.2020; 50(11): 1275.     CrossRef
Effect of urea cream on sorafenib-associated hand–foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study
Young-Sun Lee, Young K. Jung, Ji H. Kim, Sung B. Cho, Do Y. Kim, Moon Y. Kim, Hyung J. Kim, Yeon S. Seo, Ki T. Yoon, Young M. Hong, Jeong-Hoon Lee, Hyun W. Lee, Hyung J. Yim, Byoung K. Jang, Eun S. Jang, Jae Y. Jang, Sang Y. Hwang
European Journal of Cancer.2020; 140: 19.     CrossRef
Research Progress of TACE Combined with Sorafenib in the Treatment of HCC
欣 姚
Asian Case Reports in Oncology.2020; 09(04): 17.     CrossRef
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Young Chang, Soung Won Jeong, Jae Young Jang, Yong Jae Kim
International Journal of Molecular Sciences.2020; 21(21): 8165.     CrossRef
Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy
Pil Soo Sung, Moon Hyung Choi, Hyun Yang, Soon Kyu Lee, Ho Jong Chun, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Joon-Il Choi, Young Joon Lee, Si Hyun Bae
Frontiers in Oncology.2020;[Epub]     CrossRef
A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC
Jaejun Lee, Pil Soo Sung, Hyun Yang, Soon Kyu Lee, Hee Chul Nam, Sun Hong Yoo, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Jung Hyun Kwon, Jeong Won Jang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Journal of Clinical Medicine.2020; 9(12): 4121.     CrossRef
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
Keisuke Koroki, Sadahisa Ogasawara, Yoshihiko Ooka, Hiroaki Kanzaki, Kengo Kanayama, Susumu Maruta, Takahiro Maeda, Masayuki Yokoyama, Toru Wakamatsu, Masanori Inoue, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Taka
Liver Cancer.2020; 9(5): 596.     CrossRef